Literature DB >> 24676528

Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.

Eric W Price1, Jacqueline F Cawthray, Michael J Adam, Chris Orvig.   

Abstract

The ligands H2dedpa, H4octapa, p-SCN-Bn-H2dedpa, and p-SCN-Bn-H4octapa were synthesized using a new protection chemistry approach, with labile tert-butyl esters replacing the previously used methyl esters as protecting groups for picolinic acid moieties. Additionally, the ligands H2dedpa and p-SCN-Bn-H2dedpa were synthesized using nosyl protection chemistry for the first time. The use of tert-butyl esters allows for deprotection at room temperature in trifluoroacetic acid (TFA), which compares favorably to the harsh conditions of refluxing HCl (6 M) or LiOH that were previously required for methyl ester cleavage. H4octapa has recently been shown to be a very promising (111)In and (177)Lu ligand for radiopharmaceutical applications; therefore, coordination chemistry studies with Y(3+) are described to assess its potential for use with (86)Y/(90)Y. The solution chemistry of H4octapa with Y(3+) is shown to be suitable via solution NMR studies of the [Y(octapa)](-) complex and density functional theory (DFT) calculations of the predicted structure, suggesting properties similar to those of the analogous In(3+) and Lu(3+) complexes. The molecular electrostatic potential (MEP) was mapped onto the molecular surface of the DFT-calculated coordination structures, suggesting very similar and even charge distributions between both the Lu(3+) and Y(3+) complexes of octapa(4-), and coordinate structures between 8 (ligand only) and 9 (ligand and one H2O). Potentiometric titrations determined H4octapa to have a formation constant (log K(ML)) with Y(3+) of 18.3 ± 0.1, revealing high thermodynamic stability. This preliminary work suggests that H4octapa may be a competent ligand for future (86)Y/(90)Y radiopharmaceutical applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676528     DOI: 10.1039/c4dt00239c

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  5 in total

1.  A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.

Authors:  Eric W Price; Kimberly J Edwards; Kathryn E Carnazza; Sean D Carlin; Brian M Zeglis; Michael J Adam; Chris Orvig; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2016-06-28       Impact factor: 2.408

2.  Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105.

Authors:  Lily Li; María de Guadalupe Jaraquemada-Peláez; Eduardo Aluicio-Sarduy; Xiaozhu Wang; Todd E Barnhart; Weibo Cai; Valery Radchenko; Paul Schaffer; Jonathan W Engle; Chris Orvig
Journal:  Dalton Trans       Date:  2020-04-09       Impact factor: 4.390

Review 3.  The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker.

Authors:  Holis Abdul Holik; Faisal Maulana Ibrahim; Angela Alysia Elaine; Bernap Dwi Putra; Arifudin Achmad; Achmad Hussein Sundawa Kartamihardja
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

4.  What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.

Authors:  Eric W Price; Brian M Zeglis; Jacqueline F Cawthray; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Inorg Chem       Date:  2014-09-05       Impact factor: 5.165

5.  Rigidified Derivative of the Non-macrocyclic Ligand H4OCTAPA for Stable Lanthanide(III) Complexation.

Authors:  Fátima Lucio-Martínez; Zoltán Garda; Balázs Váradi; Ferenc Krisztián Kálmán; David Esteban-Gómez; Éva Tóth; Gyula Tircsó; Carlos Platas-Iglesias
Journal:  Inorg Chem       Date:  2022-03-11       Impact factor: 5.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.